Daniel E. Webster - Concepedia

Author

Daniel E. Webster

National Institutes of Health

Also Known As

D.E. Webster, Daniel E. Webster, Daniel Webster

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

National Institutes of Health National Cancer Institute VA Palo Alto Health Care System Stanford University Universitat de Barcelona

About

Daniel E. Webster is an author at National Institutes of Health specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	1.3K
2	Cell Biology	6	6	1.3K
3	Immunology	3	3	611
4	Health Sciences	1	1	96
5	Natural Sciences	1	1	267

Daniel E. Webster

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
DNMT1 maintains progenitor function in self-renewing somatic tissue George L. Sen, Jason Reuter, Daniel E. Webster, Nature Progenitor FunctionLineage PlasticityDevelopmental BiologyCell LineageMedicine	2010	432
A multiprotein supercomplex controlling oncogenic signalling in lymphoma James D. Phelan, Ryan M. Young, Daniel E. Webster, Nature Lymphoid NeoplasiaOncogenic AgentMedicineOncogenic SignallingImmunology	2018	396
Control of differentiation in a self-renewing mammalian tissue by the histone demethylase JMJD3 George L. Sen, Daniel E. Webster, Deborah I. Barragan, Genes & Development Self-renewing Mammalian TissueEpigenetic ChangeCell SpecializationEpigeneticsH3k27me3 Demethylase	2008	267
Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T Cell Leukemia/Lymphoma Masao Nakagawa, Arthur L. Shaffer, Michele Ceribelli, Cancer Cell Transcriptional RegulationT-regulatory CellImmunologyAdult T-cell Leukemia-lymphomaMedicine	2018	119
Regulation of normal B-cell differentiation and malignant B-cell survival by OCT2 Daniel J. Hodson, Arthur L. Shaffer, Wenming Xiao, Proceedings of the National Academy of Sciences	2016	105
Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma Yibin Yang, Priscilla N. Kelly, Arthur L. Shaffer, Cancer Cell Hematological MalignancyLymphoid NeoplasiaNon-proteolytic Protein UbiquitinationImmunologyHematology	2016	96
A novel model of controlling PD-L1 expression in ALK+ anaplastic large cell lymphoma revealed by CRISPR screening Jing‐Ping Zhang, Zhihui Song, Hongbo Wang, Blood	2019	68
CSNK1a1 Regulates PRMT1 to Maintain the Progenitor State in Self-Renewing Somatic Tissue Xiaomin Bao, Zurab Siprashvili, Brian Zarnegar, Developmental Cell	2017	67
Overcoming Acquired Epigenetic Resistance to BTK Inhibitors Arthur L. Shaffer, James D. Phelan, James Q. Wang, Blood Cancer Discovery	2021	56
KIR receptor‐ligand incompatibility predicts killing of osteosarcoma cell lines by allogeneic NK cells David Delgado, Daniel E. Webster, Kenneth B. DeSantes, Pediatric Blood & Cancer	2010	24

Page 1